Business description: Boston Scientific Corporation

Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:

- cardiovascular (64.2%): products used in cardiology surgeries (24.6% of net sales), peripheral surgeries (22.4%), cardiac rhythm management (21.2%), electrophysiology tests (17.7%) and other (14.1%);

- endodontic surgery (29.2%): equipment used in endoscopy (55% of net sales), and urology (45%) ;

- neuromodulation (6.6%).

Net sales are distributed geographically as follows: the United States (61%), Europe/Middle East/Africa (19.3%), Asia/Pacific (16%) and other (3.7%).

Number of employees: 53,000

Sales by Activity: Boston Scientific Corporation

Fiscal Period: December20202021202220232024

Cardiovascular (Incl. Rhythm)

3.88B 4.86B 7.83B 8.82B 10.76B

Med Surg

3.07B 3.72B 4.91B 5.42B 5.99B

Rhythm and Neuro

2.75B 3.29B - - -

Specialty Pharmaceuticals

219M 13M - - -

Other

- - -60M - -
See all business segments

Geographical breakdown of sales: Boston Scientific Corporation

Fiscal Period: December20202021202220232024

United States (U.S.)

5.7B 6.91B 7.63B 8.42B 10.21B

Europe, Middle East and Africa (EMEA)

2.1B 2.52B 2.53B 2.86B 3.23B

Asia-Pacific (APAC)

1.78B 2.07B 2.12B 2.4B 2.69B

Latin America and Canada (LACA)

307M 386M 469M 560M 624M

International

27M 4M - - -

Other Countries

- - -60M - -
See all geographic segments

Executive Committee: Boston Scientific Corporation

Manager TitleAgeSince
Chief Executive Officer 60 31/10/2011
Director of Finance/CFO 51 29/06/2025
Chief Operating Officer 57 30/04/2022
Chief Tech/Sci/R&D Officer - 31/08/2009
Corporate Officer/Principal - 28/02/2010
See BOSTON SCIENTIFIC CORPORATION governance

Composition of the Board of Directors: Boston Scientific Corporation

Director TitleAgeSince
Director/Board Member 60 31/03/2009
Chairman 60 02/05/2016
Director/Board Member 73 28/02/2014
Director/Board Member 73 14/04/2016
Director/Board Member 73 12/07/2016
Director/Board Member 62 22/06/2021
Director/Board Member 50 26/06/2023
Director/Board Member - 26/06/2023
Director/Board Member 61 07/05/2024
Director/Board Member 56 29/07/2024
Composition of the Board of Directors

Shareholders: Boston Scientific Corporation

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.347 %
138,249,447 9.347 % 14 043 M $
Fidelity Management & Research Co. LLC
6.721 %
99,412,810 6.721 % 10 098 M $
BlackRock Advisors LLC
6.627 %
98,012,423 6.627 % 9 956 M $
4.39 %
64,925,564 4.39 % 6 595 M $
BlackRock Life Ltd.
2.377 %
35,161,990 2.377 % 3 572 M $
NameEquities%Valuation
Empiricus Gestao De Recursos Ltda.
0.000442 %
6,551 0.000442 % 662 898 $
BRAM - Bradesco Asset Management SA DTVM
0.000079 %
1,170 0.000079 % 118 393 $
XP Allocation Asset Management Ltda.
0.00002 %
295 0.00002 % 29 851 $
List of BOSTON SCIENTIFIC CORPORATION shareholders

Holdings: Boston Scientific Corporation

NameEquities%Valuation
3,180,000 9.83% 14,119,868 $

Company details: Boston Scientific Corporation

Boston Scientific Corp.

300 Boston Scientific Way

01752-1234, Marlborough

+508 683 4000

http://www.bostonscientific.com
address Boston Scientific Corporation(BSX)

Group companies: Boston Scientific Corporation

NameCategory and Sector
Boston Scientific Technology & Engineering Services Pvt Ltd.
Boston Scientific Technology & Engineering Services Pvt Ltd.
Boston Scientific Asia Pacific Pte Ltd.
See all subsidiaries

Other Advanced Medical Equipment & Technology

Change 5d. change 1-year change 3-years change Capi.($)
+0.18%-5.96%+2.77%+100.52% 137B
+1.91%-1.14%+7.08%+2.42% 212B
-0.40%-2.42%+3.31%+105.44% 198B
+3.22%+0.86%-1.67%-14.45% 158B
-1.23%+2.08%-19.26%-13.55% 56.88B
+0.77%-0.07%+14.35%+13.39% 48.33B
+2.01%-3.88%+1.09%-6.20% 39.81B
+1.73%+1.05%+2.56% - 37.82B
+2.02%+0.02%+2.56%+14.48% 35.93B
-0.36%-0.75%-24.71%-36.42% 34.02B
Average +0.53%-1.06%-1.19%+18.40% 95.7B
Weighted average by Cap. +0.57%-1.51%+1.32%+34.59%
See all sector performances
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
92.70USD
Average target price
126.48USD
Spread / Average Target
+36.44%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. BSX Stock
  4. Company Boston Scientific Corporation